CONMED (CNMD) News Today

Fisher Asset Management LLC cut its holdings in CONMED Co. (NYSE:CNMD - Free Report) by 8.3% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 278,134 shares of the company's stock after selling 25,162 sha

CONMED Co. (NYSE:CNMD - Get Free Report) insider Stanley W. Peters III sold 4,000 shares of the stock in a transaction dated Friday, June 14th. The shares were sold at an average price of $71.82, for a total value of $287,280.00. Following the completion of the transaction, the insider now owns 63 shares in the company, valued at approximately $4,524.66. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

Congress Asset Management Co. MA lifted its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 8.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 302,467 shares of the company's stock after acqu

CONMED Co. (NYSE:CNMD - Get Free Report) has earned an average recommendation of "Moderate Buy" from the six ratings firms that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and five have given a buy recommendation to the com

Intrinsic Edge Capital Management LLC boosted its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 672.5% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 77,248 shares of the company's s

Sectoral Asset Management Inc. cut its position in shares of CONMED Co. (NYSE:CNMD - Free Report) by 84.1% during the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,100 shares of the company's stock after selling 95,900 shares during the qua

Campbell & CO Investment Adviser LLC cut its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 68.2% during the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 6,828 shares of the company's stock after selling 14,644

Capital Research Global Investors grew its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 11.8% during the fourth quarter, according to the company in its most recent disclosure with the SEC. The fund owned 2,757,108 shares of the company's stock after buying an additional 289,996 sh

CONMED Co. (NYSE:CNMD - Get Free Report) was the target of a large increase in short interest in the month of May. As of May 15th, there was short interest totalling 3,660,000 shares, an increase of 5.2% from the April 30th total of 3,480,000 shares. Based on an average daily trading volume, of 520,800 shares, the days-to-cover ratio is currently 7.0 days.

Dimensional Fund Advisors LP increased its holdings in shares of CONMED Co. (NYSE:CNMD - Free Report) by 5.0% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 712,332 shares of the company's stock after purch

CONMED Co. (NYSE:CNMD) announced a quarterly dividend on Wednesday, May 22nd. Shareholders of record on Friday, June 14th will be given a dividend of 0.20 per share on Friday, July 5th. This represents a $0.80 annualized dividend and a yield of 1.09%. The ex-dividend date of this dividend is Friday, June 14th.

CONMED Co. (NYSE:CNMD - Get Free Report) has received an average rating of "Moderate Buy" from the seven ratings firms that are covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation and six have given a buy recommendation to the company. The ave

Principal Financial Group Inc. trimmed its stake in CONMED Co. (NYSE:CNMD - Free Report) by 2.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 600,334 shares of the company's stock after selling 13,021 shares dur

CONMED Co. (NYSE:CNMD - Get Free Report) Director Barbara J. Schwarzentraub purchased 1,442 shares of CONMED stock in a transaction that occurred on Wednesday, May 8th. The stock was acquired at an average price of $69.26 per share, with a total value of $99,872.92. Following the transaction, the director now owns 1,442 shares in the company, valued at $99,872.92. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

CONMED Co. (NYSE:CNMD - Get Free Report) Director Martha Goldberg Aronson bought 2,000 shares of the firm's stock in a transaction dated Monday, May 6th. The shares were acquired at an average price of $70.98 per share, for a total transaction of $141,960.00. Following the completion of the transaction, the director now directly owns 2,000 shares in the company, valued at approximately $141,960. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website.

Lisanti Capital Growth LLC purchased a new position in shares of CONMED Co. (NYSE:CNMD - Free Report) during the 4th quarter, according to the company in its most recent filing with the SEC. The institutional investor purchased 40,570 shares of the company's stock, valued at approximately $4,443,0

Needham & Company LLC restated a "buy" rating and issued a $107.00 price target on shares of CONMED in a research note on Monday.

Fisher Asset Management LLC lowered its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 8.4% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 277,809 shares of the company's stock

CONMED Co. (NYSE:CNMD - Get Free Report) COO Pat Beyer bought 3,000 shares of CONMED stock in a transaction on Tuesday, April 30th. The stock was acquired at an average cost of $68.30 per share, for a total transaction of $204,900.00. Following the acquisition, the chief operating officer now owns 10,807 shares in the company, valued at approximately $738,118.10. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website.

Mountain Pacific Investment Advisers Inc. ID raised its position in CONMED Co. (NYSE:CNMD - Free Report) by 33.3% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 192,426 shares of the company's stock after purchasing a

JPMorgan Chase & Co. dropped their price objective on shares of CONMED from $115.00 to $75.00 and set an "overweight" rating for the company in a report on Thursday.

Jennison Associates LLC trimmed its stake in shares of CONMED Co. (NYSE:CNMD - Free Report) by 5.4% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 345,115 shares of the company's stock after sellin

CONMED (NYSE:CNMD) updated its FY 2024 earnings guidance. The company provided EPS guidance of 4.250-4.350 for the period, compared to the consensus estimate of 4.330. The company also issued revenue guidance of $1.3 billionillion-$1.4 billionillion, compared to the consensus estimate of $1.4 billionillion.

CONMED (NYSE:CNMD) Sets New 1-Year Low at $70.34